• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcarePharmaceuticalsCelularity
    Picture of Celularity logo

    CELU — Celularity News Story

    $0.980.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapNeutral
    • Market Cap
      $31.73m
    • Enterprise Value
      $72.46m
    • Revenue
      $26.55m
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • CELU Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    CELU Dividends
    All News

    NASDAQ RESUMED AT 02:07 PM

    Picture of Celularity logoCelularity
    16/07/2021 19:08
    NASDAQ RESUMED  GXGXU.O  AT 02:07 PM
    

    Recent news on Celularity

    See all news
    • U.S. STOCKS ON THE MOVE-BWX Technologies, Synopsys,Burlington Stores

      27/08/2026 18:55
    • U.S. STOCKS ON THE MOVE-Jazz Pharmaceuticals, Celularity, Infleqtion

      27/08/2026 16:59
    • Celularity hits over 4-month high on deal to manufacture MuseCell's cell therapy platform

      27/08/2026 15:35
    • Celularity rises on deal to manufacture MuseCell's cell therapy platform

      27/08/2026 15:15
    • Brief: Celularity And MuseCell Innovations® Announce U.S. Manufacturing Collaboration For The Dezawa Musecell® Platform

      27/08/2026 14:13

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.